|
SLXN Biomotion Sciences 2022416 |
| Income Statement |
|
Net Income
|
zk2532833
|
-11,860,000 |
| Balance Sheet |
|
Current Assets
|
3,047,000 |
|
Assets
|
3,087,000 |
|
Current Liabilities
|
3,583,000 |
|
Liabilities
|
7,666,000 |
|
Equity
|
-4,579,000 |
|
Shares Out
|
9,768,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,653,000 |
|
Investing Cash Flow
|
-16,000 |
| Market Analysis |
Market Cap
|
9,362,030 |
|
Price
|
1.13 |
|
BVPS
|
0.42 |
|
PB
|
2.75 |
|
EPS
|
-0.14 |
|
PS
|
29.65 |
|
FCF
|
-2,669,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLXN documents filed with the SEC.
SLXN Filings
Clear
